Events & Presentations

Mar 21, 2018 Processa Pharmaceuticals Announces That It Has Been Assigned The License For The Clinical Stage Compound Ctp-499 And Plans To Develop The Drug In Multiple Unmet Medical Need Conditions
Mar 11-14, 2018 Roth Capital Partners Annual Conference
March 11-14, 2018
Orange County, CA
> Download Processa Pharmaceuticals Roth Conference Presentaiton
Dec 5, 2017 Processa Pharmaceuticals December 2017 Corporate Presentation

Jan 8-11, 2018

Attending and Meeting Investors
J.P. Morgan 36th Annual Healthcare Conference
January 8-11, 2018
San Francisco, California
Dec 5, 2017 10th Annual LD Micro Main Event
Tuesday, Dec 5 at 1:30-2:00 PM in Track 5
Presenter: Patrick Lin, David Young
Los Angeles, California
Nov 13-15, 2017 3rd Annual Emerging Growth Conference
November 13-15, 2017
Rancho Santa Fe, California